Since YAP/TAZ and Yki are oncogenes, it is paradoxical that halving the gene dosage of hpo or ex, both of which are Yki inhibitors and recognized/putative tumor suppressors, should inhibit adenoma growth. Here, YAP1 is linked to neoplasm.